Douglas W. Blayney, MD is the Ann and John Doerr Medical Director of the Stanford University Cancer Center and a Professor of Internal Medicine. He is immediate past president of the American Society of Clinical Oncology (ASCO). He came to Stanford after 7 years in a similar position at the University of Michigan in Ann Arbor; previously he was with Wilshire Oncology Medical Group in Pasadena, California, where he practiced for 17 years. Dr. Blayney has served on the FDA’s Oncology Drug Advisory Committee, as founding editor-in-chief of ASCO’s Journal of Oncology Practice, and was a founder of ASCO’s internet site, Asco.org. He has authored or coauthored over fifty peer reviewed journal articles, and co-edited one book. His current research involves measuring and improving quality of cancer care using information technology. Dr. Blayney received a degree in electrical engineering from Stanford, went on to the University of California, San Diego, from which he received his medical degree in 1977, and was an intern and resident in internal medicine at their University of California hospitals. He trained in oncology at the National Cancer Institute and is board certified in internal medicine and medical oncology.
